Skip to main content

RANI- Rani Therapeutics Holdings, Inc.

Insider activity in RANI over the last quarter tilts toward buying: insiders added a net 71,000 shares worth roughly $50K. In the past 30 days, 2 insiders bought and 0 sold. The tilt toward buying has held up recently.

IMRAN MIR A (Director, 10% Owner) stands out among recent buyers, now holding an estimated $1.5M in RANI.

RANI sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

RoleInsiderSharesValue30d
10%2.38M$1.92M-
10%2.12M$1.71M+36.0K
CEO469.7K$378.6K+35.0K
Dir247.2K$199.2K-
Dir123.6K$99.6K-

Activity

Buys and sells only

Transactions

10 filings
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Jul 21, 2026Imran Mir ADirector, 10% OwnerBuy36,000$0.69$24,840.00+1.7%--
Jul 17, 2026Imran Talat53Chief Executive OfficerBuy35,000$0.72$25,193.00+8.1%--
Mar 27, 2026Javadi AlirezaChief Technical OfficerSell386$0.78$301.08-3.8%--
Oct 23, 2025Imran Mir ADirector, 10% OwnerBuy2,083,334$0.61$1,260,417.07New-35.4%-
Oct 21, 2025South Cone Investments Limited Partnership4710% OwnerSell5,923,000$2.65$15,711,314.50-40.3%-52.3%-
Dec 27, 2024Imran Talat53Chief Executive OfficerSell8,014$1.41$11,299.74-1.6%--
Dec 13, 2024McKinley KateChief Business OfficerBuy17,960$1.67$29,993.20New-12.0%-19.3%
Dec 9, 2024Imran Talat53Chief Executive OfficerBuy10,296$1.94$19,974.24+2.1%-23.3%-19.7%
Oct 15, 2024South Cone Investments Limited Partnership4710% OwnerSell3,829,360$2.65$10,141,673.58-18.3%-38.7%-76.9%
Dec 6, 2023Imran Talat53Chief Executive OfficerBuy10,000$2.27$22,700.00+2.1%+48.8%-26.6%
Page 1Next →

Understand these filings